|
KMID : 0043320030260110892
|
|
Archives of Pharmacal Research
2003 Volume.26 No. 11 p.892 ~ p.897
|
|
|
Synthesis and Characterization of the Tumor Targeting Mitoxantrone-Insulin Conjugate
|
|
Liu Wen-Sheng
Yuan-Huang
Zhang Zhi-rong
|
|
|
Abstract
|
|
|
|
Anticancer drugs have serious side effects arising from their poor malignant cells selectivity, Since insulin receptors highly express on the cytomembrane of some kind of tumor cells, using insulin as the vector was expected to reduce serious side effects of the drugs. The objective of this study was to evaluate the tumor targeting effect of the newly synthesized mitoxantrone-insulin conjugate (MIT-INS) with the drug loading of 11.68%. In vitro stability trials showed MIT-INS were stable in buffers with different pH (2-8) at within 120 h (less than 3% of free MIT released), and were also stable in mouse plasma within 48 h (less than 1 % of free MIT released). In vivo study on tumor-bearing mice showed that, compared with MIT [75.92 h/g of the area under the concentration-time curve (AUC) and 86.85 h of mean residence time (MRT)], the conjugates had better tumor-targeting efficiency with enhanced tumor AUC of 126.53 1l9 h/g and MTR of 151.95 h. The conjugate had much lower toxicity to most other tissues with targeting indexes () no larger than 0.3 besides good tumor targeting efficiency with of 1.67. The results suggest the feasibility to promote the curative effect in ca.ncer chemotherapy by using insulin as the vector of anti-cancer drugs.
|
|
|
KEYWORD
|
|
|
Mitoxantrone-insulin conjugate, Vector, Anti-cancer drug, Targeting
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|